A ARISAPH CREATING SMART MEDICINES
Dead / Cancelled — Cancelled — Section 8 (as of 24 May 2019)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77096989
- Registration number
- 3521328
- Mark type
- Design + words
- Filed
- 01 Feb 2007
- Published for opposition
- 31 Jul 2007
- Registered
- 21 Oct 2008
- Attorney of record
- Joshua Jarvis, Esq.
Goods and services
- Class 042 — Scientific and technological services: Biotechnology and pharmaceutical research and development services
Owner
- Arisaph Pharmaceuticals, Inc., Boston, MA, US
- Arisaph Pharmaceuticals, Inc., Boston, MA, US
- Arisaph Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 24 May 2019 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 21 Oct 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 16 May 2014 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 16 May 2014 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Nov 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Nov 2013 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 25 Oct 2013 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 13 Nov 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Oct 2013 — TEAS SECTION 8 & 15 RECEIVED
- 21 Oct 2008 — REGISTERED-PRINCIPAL REGISTER
- 16 Sept 2008 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 16 Sept 2008 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Sept 2008 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Aug 2008 — USE AMENDMENT FILED
- 04 Sept 2008 — CASE ASSIGNED TO INTENT TO USE PARALEGAL